Fortress Biotech Ownership | Who Owns Fortress Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Fortress Biotech Ownership Summary


Fortress Biotech is owned by 17.53% institutional investors, 20.97% insiders, and 61.49% retail investors. Summit financial is the largest institutional shareholder, holding 3.84% of FBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.97% of its assets in Fortress Biotech shares.

FBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFortress Biotech17.53%20.97%61.49%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Summit financial1.02M3.84%$1.89M
Nantahala capital management325.52K1.23%$605.47K
Shikiar asset management278.47K1.05%$518.00K
Blackrock funding, inc. /de132.09K0.50%$245.68K
Atria investments88.81K0.34%$165.19K
Pfg investments55.42K0.21%$103.08K
Weaver consulting group44.92K0.17%$83.55K
Cetera investment advisers39.15K0.15%$72.82K
Choreo36.25K0.14%$67.42K
Xtx topco22.79K0.09%$42.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Shikiar asset management278.47K0.14%$518.00K
Summit financial1.02M0.04%$1.89M
Nantahala capital management325.52K0.02%$605.47K
Weaver consulting group44.92K0.02%$83.55K
Pfg investments55.42K0.01%$103.08K
Two sigma securities13.63K0.00%$25.36K
Atria investments88.81K0.00%$165.19K
Xtx topco22.79K0.00%$42.39K
Choreo36.25K0.00%$67.42K
Newedge advisors11.20K0.00%$20.83K

Top Buyers

HolderShares% AssetsChange
Summit financial1.02M0.04%1.02M
Shikiar asset management278.47K0.14%42.50K
Xtx topco22.79K0.00%22.79K
Blackrock funding, inc. /de132.09K-16.30K
Two sigma securities13.63K0.00%13.63K

Top Sellers

HolderShares% AssetsChange
Cambridge investment research advisors---1.00M
B. riley wealth advisors---144.70K
Hb wealth management---113.35K
Acadian asset management18.56K0.00%-71.95K
Gsa capital partners llp---60.47K

New Positions

HolderShares% AssetsChangeValue
Summit financial1.02M0.04%1.02M$1.89M
Two sigma securities13.63K0.00%13.63K$25.36K
Newedge advisors11.20K0.00%11.20K$20.83K
National bank of canada /fi/10.60K-10.60K$19.72K
Raymond james financial26.00-26.00$48.00

Sold Out

HolderChange
Wells fargo & company/mn-16.00
Citigroup-193.00
Tower research capital llc (trc)-1.97K
Meridian wealth management-10.00K
Renaissance-32.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025514.08%4,637,257-5.60%175.08%2728.57%12-
Mar 31, 202548-12.73%4,440,118-7.34%163.16%20-39.39%129.09%
Dec 31, 2024553.77%4,791,9487.76%234.52%3332.00%11-15.38%
Sep 30, 202453-1.85%4,447,05222.70%225.77%25-7.41%138.33%
Jun 30, 20245422.73%3,624,23623.64%196.77%2717.39%1220.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv585.25K1.97%-12.79K
Vanguard US Total Market Shares ETF470.54K1.59%-
Vanguard Institutional Extnd Mkt Idx Tr200.45K0.67%-52.40K
Fidelity Extended Market Index112.86K0.38%-295.00
iShares Micro-Cap ETF52.60K0.18%-
Fidelity Total Market Index49.88K0.17%-
NT Ext Equity Mkt Idx Fd - NL45.89K0.16%28.57K
NT Ext Equity Mkt Idx Fd - DC - NL - T235.63K0.12%22.15K
Fidelity Series Total Market Index29.00K0.10%-
Spartan Extended Market Index Pool F24.47K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Jul 11, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$37.42K
Jul 10, 2024Jin David Chief Financial OfficerBuy$3.75K
Jul 09, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$36.97K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q36-
2024 Q221

FBIO Ownership FAQ


Who Owns Fortress Biotech?

Fortress Biotech shareholders are primarily institutional investors at 17.53%, followed by 20.97% insiders and 61.50% retail investors. The average institutional ownership in Fortress Biotech's industry, Biotech Stocks , is 304.14%, which Fortress Biotech falls below.

Who owns the most shares of Fortress Biotech?

Fortress Biotech’s largest shareholders are Summit financial (1.02M shares, 3.84%), Nantahala capital management (325.52K shares, 1.23%), and Shikiar asset management (278.47K shares, 1.05%). Together, they hold 6.12% of Fortress Biotech’s total shares outstanding.

Does Blackrock own Fortress Biotech?

BlackRock is not among the top 10 institutional shareholders of Fortress Biotech.

Who is Fortress Biotech’s biggest shareholder by percentage of total assets invested?

Shikiar asset management is Fortress Biotech’s biggest shareholder by percentage of total assets invested, with 0.14% of its assets in 278.47K Fortress Biotech shares, valued at 518K$.

Who is the top mutual fund holder of Fortress Biotech shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fortress Biotech shares, with 1.97% of its total shares outstanding invested in 585.25K Fortress Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools